Skip to content
Clinical Trials – home

Pituitary-dependent Cushing's syndrome Diagnostics

1 / 4 trials open to patients12 countries

In short

Getting a correct diagnosis for pituitary-dependent Cushing's syndrome is a journey that requires patience and thorough testing. Understanding when to seek evaluation and what diagnostic steps are involved can help you navigate this complex process with more confidence.

Key points

  • Pituitary-dependent Cushing's syndrome is diagnosed through multiple types of tests because no single test can definitively confirm the condition on its own.
  • The average person waits five to seven years from symptom onset to diagnosis, making it crucial to be persistent if you suspect you have this condition.
  • Late-night saliva testing is one of the simplest yet most effective ways to detect abnormal cortisol patterns, as healthy people have low cortisol at night while those with Cushing's remain high.
  • Pituitary tumors causing this disease are often so small they don't show up on MRI scans, which means additional specialized testing may be needed to locate the source.
  • Women are three times more likely than men to develop pituitary-dependent Cushing's syndrome, typically between ages 30 and 60.
  • Clinical trials for Cushing's syndrome require comprehensive baseline testing not just to confirm diagnosis but also to measure the condition's impact on quality of life and overall health.
  • Some patients have "cyclical" Cushing's where symptoms and test results come and go, making diagnosis particularly challenging and sometimes requiring repeated testing over extended periods.
  • Early diagnosis and treatment significantly improve outcomes, as prolonged exposure to high cortisol can cause permanent damage to bones, the heart, and other organs.

Introduction: When Should You Seek Diagnostic Testing?

If you have been experiencing unusual symptoms like rapid weight gain around your stomach and face, along with thinning skin that bruises easily, it may be time to talk to your doctor about pituitary-dependent Cushing's syndrome. This condition develops when a small tumor in your pituitary gland causes your body to produce too much of a hormone called cortisol, which is often referred to as the "stress hormone." Because cortisol affects so many different systems in your body, the symptoms can be wide-ranging and sometimes confusing.

People who should consider seeking diagnostic testing are those experiencing a combination of physical changes and symptoms that don't seem to have another clear explanation. You might notice that your face has become rounder, sometimes described as a "moon face," or that you have developed a fatty lump between your shoulder blades, called a buffalo hump. Other common signs include purple or pink stretch marks on your stomach, hips, thighs, breasts, or underarms. These stretch marks are different from typical ones because they tend to be wider and more colorful.

Beyond physical appearance changes, many people with this condition experience muscle weakness, particularly in their arms and legs, making it difficult to perform everyday tasks like climbing stairs or lifting objects. Women may notice that their menstrual periods have become irregular or stopped completely, while men might experience erectile dysfunction. If you have developed high blood pressure, diabetes, or brittle bones without a clear reason, these could also be signs that warrant further investigation.

It's important to understand that this condition typically develops gradually over months or years, which means the symptoms may appear slowly and be easy to dismiss at first. This is one reason why it can take five to seven years on average before someone receives a proper diagnosis. The condition most commonly affects adults between the ages of 30 and 60, and it occurs about three times more often in women than in men.

Classic Diagnostic Methods Used to Identify the Disease

Diagnosing pituitary-dependent Cushing's syndrome can be a long and complex process because many other illnesses have similar symptoms. Your doctor will likely start with a thorough physical examination, looking for the characteristic signs of the condition such as a rounded face, a hump on the back of your neck, and thin, easily bruised skin with stretch marks. They will also review your complete medical history and ask detailed questions about when your symptoms began and how they have progressed over time.

The first step in laboratory testing usually involves measuring the levels of cortisol in your body. Because cortisol levels naturally rise and fall throughout the day, with higher levels in the morning and lower levels at night, doctors use several different types of tests to get a complete picture. One common approach is the 24-hour urine collection test, where you collect all of your urine over a full day and night. This sample is then analyzed to measure the total amount of cortisol your body is producing.

Blood tests are also used to measure cortisol and another hormone called ACTH (adrenocorticotropic hormone), which is produced by the pituitary gland. In pituitary-dependent Cushing's syndrome, both cortisol and ACTH levels are typically elevated because the pituitary tumor is producing too much ACTH, which in turn tells your adrenal glands to make too much cortisol. By measuring both hormones, doctors can begin to understand where the problem is originating.

A particularly useful test is the late-night salivary cortisol test. In healthy people, cortisol levels drop significantly in the evening. To perform this test, you simply provide a small sample of saliva collected at night, usually around 11 PM or midnight. If your cortisol levels remain high when they should be low, this suggests your body's normal hormone regulation is not working properly, which is a hallmark of Cushing's syndrome.

Another important diagnostic tool is the low-dose dexamethasone suppression test. Dexamethasone is a synthetic form of cortisol, and in healthy people, taking this medication should signal the body to stop producing its own cortisol. During this test, you take a low dose of dexamethasone, usually at night, and then your cortisol levels are measured the next morning. If your cortisol levels remain high despite taking the medication, it indicates that your body's feedback system is not responding normally, which is consistent with Cushing's syndrome.

Once initial testing confirms that cortisol levels are abnormally high, your doctor will want to determine whether the excess cortisol is coming from a pituitary tumor or from somewhere else in your body. This requires additional specialized tests. A high-dose dexamethasone suppression test uses a larger amount of the medication to see if it can suppress cortisol production. In pituitary-dependent Cushing's syndrome, the high dose often does suppress cortisol somewhat, while in other forms of the condition it does not.

Imaging tests play a crucial role in confirming the diagnosis and locating the source of the problem. An MRI scan of your pituitary gland is typically performed to look for the presence of a tumor. However, these tumors are often very small, sometimes less than half a centimeter in diameter, which means they can be difficult to see even with advanced imaging techniques. Some tumors may not show up on imaging at all, which doesn't necessarily mean they're not there.

In cases where the diagnosis is still uncertain after these tests, doctors may recommend a procedure called inferior petrosal sinus sampling. This is a more invasive test where thin tubes called catheters are inserted through blood vessels in your groin and guided up to the veins that drain blood from your pituitary gland. Blood samples are taken from these veins and compared to samples from other parts of your body. If the ACTH levels are much higher in the blood coming from the pituitary area, it confirms that the pituitary gland is the source of the problem.

Throughout the diagnostic process, your doctor will also perform tests to assess the impact that high cortisol levels have had on your overall health. This typically includes checking your blood sugar levels to screen for diabetes, measuring your blood pressure, and possibly ordering a bone density scan to check for osteoporosis. These assessments help your healthcare team understand the full extent of how the condition has affected your body and guide treatment decisions.

Diagnostics for Clinical Trial Qualification

When patients with pituitary-dependent Cushing's syndrome are being considered for enrollment in clinical trials, they typically undergo a standardized set of diagnostic tests to confirm their diagnosis and establish baseline measurements. These tests serve multiple purposes: they ensure that participants truly have the condition being studied, they help researchers understand the severity of each person's disease, and they provide a starting point for measuring whether experimental treatments are working.

Clinical trials for this condition generally require comprehensive hormone testing to document abnormal cortisol production. This typically includes the same tests used in standard diagnosis, such as 24-hour urine cortisol measurements, blood tests for cortisol and ACTH levels, and late-night salivary cortisol testing. However, clinical trials often have specific threshold values that must be met for a patient to qualify. For example, a trial might require that your 24-hour urine cortisol level is at least 1.5 times higher than the upper limit of normal, ensuring that participants have clearly elevated cortisol levels.

Imaging studies are another essential component of clinical trial screening. Most trials require an MRI scan of the pituitary gland to document the presence and size of the tumor. Some studies may focus specifically on patients with small tumors (called microadenomas) that are less than one centimeter in size, while others might include patients with larger tumors (macroadenomas). Understanding the size and characteristics of your tumor helps researchers ensure that the study population is appropriate for the treatment being tested.

Trials often include comprehensive medical assessments to evaluate the complications that have resulted from prolonged exposure to high cortisol levels. This might include glucose tolerance tests or hemoglobin A1c measurements to assess diabetes or pre-diabetes, blood pressure monitoring to document hypertension, bone density scans to evaluate osteoporosis, and various blood tests to check cholesterol levels and kidney function. These assessments help researchers understand each participant's overall health status and monitor for any changes during the trial.

Some clinical trials use quality of life questionnaires and cognitive function tests as part of their baseline evaluation. Since pituitary-dependent Cushing's syndrome often causes depression, anxiety, memory problems, and difficulty concentrating, these assessments provide important information about how the condition is affecting daily functioning. They also serve as outcome measures to determine whether a treatment improves not just hormone levels but also the symptoms that matter most to patients.

Before enrolling in a clinical trial, you will also undergo a thorough review of your medical history and current medications. This is important because certain medications or other health conditions might interfere with the study treatment or make it unsafe for you to participate. Your healthcare team will explain all the required tests and help you understand what the screening process involves before you make a decision about participating in research.

Prognosis and Survival Rate

Prognosis

The outlook for people with pituitary-dependent Cushing's syndrome depends largely on how quickly the condition is diagnosed and how effectively it is managed. If left untreated, the disease is progressive, meaning it gets worse over time, and can lead to serious health complications. Prolonged exposure to high cortisol levels can result in heart disease, blood clots, infections, diabetes, osteoporosis, and severe mental health issues including depression. In the most severe cases, untreated Cushing's syndrome can be life-threatening.

However, when treatment is started promptly, many of the symptoms and complications can improve significantly or even resolve completely. After successful treatment, patients often experience weight loss, improvement in blood pressure and blood sugar levels, better bone density, healing of the skin, and restoration of menstrual cycles in women. Mental health symptoms such as depression and anxiety also tend to improve once cortisol levels return to normal. The sooner treatment begins, the better the chances for recovery and the lower the risk of permanent damage to organs and tissues.

It's important to understand that even after successful initial treatment, such as surgery to remove the pituitary tumor, some patients may experience a recurrence of the condition. Studies indicate that approximately 13% of patients who initially achieve remission after surgery may have their disease return within 10 years. This means that long-term follow-up with regular monitoring of cortisol levels is essential to ensure the condition remains under control.

Survival Rate

While specific survival rate statistics for pituitary-dependent Cushing's syndrome are not provided in standard medical references, it is well established that untreated or poorly managed Cushing's syndrome significantly increases the risk of death from cardiovascular complications, infections, and other serious health problems. The condition can be fatal if left untreated.

With appropriate treatment, however, most patients can achieve good outcomes and live active, healthy lives. The key factors that influence prognosis include early diagnosis, effective treatment of the underlying pituitary tumor, proper management of complications such as diabetes and high blood pressure, and regular medical follow-up to detect and address any recurrence of the disease. Patients who receive comprehensive care from specialists, particularly endocrinologists who focus on hormone disorders, tend to have the best outcomes.

Did you know?

  1. The late-night saliva test for Cushing's syndrome is so simple you can do it at home—just spit in a tube before bed—yet it's one of the most reliable ways to detect abnormal cortisol patterns.
  2. Pituitary tumors that cause Cushing's disease are often so tiny (less than 5 millimeters) that they can be invisible even on the most advanced MRI scanners, making diagnosis a real detective challenge for doctors.
  3. Some people with Cushing's syndrome have "cyclical" disease where their symptoms and test results come and go unpredictably over months or years, which can lead to doctors initially thinking the patient's symptoms are psychological rather than physical.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Pituitary-dependent Cushing's syndrome

Recruiting trials first

See all 4 trials →
Quick filters

4 clinical trials in this condition

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:ATUMELNANT
  • Sponsor:Crinetics Pharmaceuticals Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Clofutriben
  • Sponsor:Sparrow Pharmaceuticals Inc.
Registered drug
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Osilodrostat
  • Sponsor:Recordati AG
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ag13909
  • Sponsor:H. Lundbeck A/S
See all 4 trials →filters applied: condition = Pituitary-dependent Cushing's syndrome

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).